These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7191570)

  • 21. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914
    [No Abstract]   [Full Text] [Related]  

  • 22. Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic, thioridazine.
    Bentall AC; Herberg LJ
    Neuropharmacology; 1980 Aug; 19(8):699-703. PubMed ID: 7191488
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychopharmacological effects of low and high doses of apomorphine during ontogeny.
    Shalaby IA; Spear LP
    Eur J Pharmacol; 1980 Oct; 67(4):451-9. PubMed ID: 7192634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic thioridazine treatment differently affects DA receptors in striatum and in mesolimbo-cortical systems.
    Piazza PV; Calzà L; Giardino L; Amato G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):937-42. PubMed ID: 2345767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Locomotor activity and stereotypy in rats following repeated apomorphine treatments at 1-, 3-, or 7-day intervals.
    Mattingly BA; Gotsick JE; Marin C
    Pharmacol Biochem Behav; 1988 Dec; 31(4):871-5. PubMed ID: 3252279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 28. Dose-related response of male rats to apomorphine: snout contact in the open-field.
    Beck CH; Chow HL; Cooper SJ
    Physiol Behav; 1986; 37(5):819-25. PubMed ID: 3774911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison.
    Ljungberg T
    J Pharm Pharmacol; 1986 Jul; 38(7):520-5. PubMed ID: 2875153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choline chloride in methylphenidate- and apomorphine-induced stereotypy.
    Davis KL; Hollister LE; Vento AL; Simonton S
    Life Sci; 1978 Jun; 22(24):2171-7. PubMed ID: 566835
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of alpha-adrenergic blocking agents on stereotyped behavior induced by apomorphine in rats.
    De-Souza H; Palermo-Neto J
    Braz J Med Biol Res; 1982 Jul; 15(2-3):143-6. PubMed ID: 6891277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the stereotypy response but not the hypomotility response to apomorphine in the Roman High and Low avoiding strains of rats.
    Durcan MJ; Fulker DW; Campbell IC
    Psychopharmacology (Berl); 1984; 82(3):215-20. PubMed ID: 6425902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():335-40. PubMed ID: 7190762
    [No Abstract]   [Full Text] [Related]  

  • 35. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Bloom AS; Sadowski JA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chronic chlorpromazine administration or prior treatment with reserpine on brain apomorphine concentrations and apomorphine-induced sterotyped behaviour in the rat.
    Symes AL; Lal S; Young SN; Tsang D; Sourkes TL
    Eur J Pharmacol; 1977 May; 43(2):173-9. PubMed ID: 559575
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of clozapine, thioridazine and phenoxybenzamine on the action of drugs stimulating the central catecholamine receptors.
    Maj J; Sowińska H; Baran L; Kapturkiewicz Z
    Pol J Pharmacol Pharm; 1974; 26(4):437-48. PubMed ID: 4472362
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
    Barghon R; Protais P; Colboc O; Costentin J
    Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.